Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|December 15, 2007
Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control groupP Airò, M Rossi, M Scarsi, et al.
Reumatismo|April 25, 2008
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseasesS Zingarelli, P Airò, M Frassi, et al.
Clinical and Experimental Rheumatology|January 5, 2008
Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitionersP Airò, E Tabaglio, M Frassi, et al.
Reumatismo|July 25, 2008
[Long-term effects of cyclic therapy with iloprost in systemic sclerosis]M Scarsi, M Rossi, E Danieli, et al.
Lupus|July 16, 2008
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseasesI Cavazzana, A Ceribelli, M Quinzanini, et al.
Minerva Pediatrica|April 1, 1990
[Scoliosis and lateral gaze paralysis. Description of a case and review of the literature]S Rolando, M E Celle, M Scuderi, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|February 2, 1999
Surgical treatment of scoliosis associated with myelomeningoceleG Stella, E Ascani, S Cervellati, et al.
Clinical and Experimental Rheumatology|January 17, 2014
Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritisM Scarsi, C Zanotti, M Chiarini, et al.
Lupus|March 25, 2015
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin DS Piantoni, L Andreoli, M Scarsi, et al.
Clinical and Experimental Rheumatology|June 5, 2007
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phaseP Airò, E Danieli, M Rossi, et al.
Pageof 3